TABLE 2.
List of IE-1 epitope variants used in this study
| Epitope | HLA restriction | Sequence position | Major epitope varianta | Amino acid variant(s) (position) | Reference(s) |
|---|---|---|---|---|---|
| KARAKKDELR | A31 | 192–201 | KARAKKDELK | R/K (10) | This study |
| ARAKKDELR | B27 | 193–201 | ARAKKDELK | R/K (9) | This study |
| DELRRKMMY | B18, B44 | 198–206 | DELKRKMIY | R/K (4), M/I (8) | 17 |
| ELRRKMMYM | B8 | 199–207 | ELKRKMIYM | R/K (3), M/I (7) | 19 |
| RRKMMYMYCR | B27 | 201–210 | KRKMIYMYCR | R/K (1), M/I (5) | This study |
| AYAQKIFKIL | A23 | 248–257 | TYSQKIFKIL | A/T (1), A/S (3) | 20, 21 |
| VLEETSVML | A2 | 316–324 | YILEETSVML | V/I (1 or 2) | 18 |
| EEAIVAYTL | B18, B44 | 381–390 | EDAIAAYTL | E/D (2), V/A (5) | 17 |
a
Changes are indicated by bold type and underlining.